BiotechTube

Acetaminophen + Maxigesic 325 + Ibuprofen + Placebo

Phase 3Withdrawn
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Osteoarthritis

Conditions

Osteoarthritis

Trial Timeline

— → —

NCT ID
NCT01420666

About Acetaminophen + Maxigesic 325 + Ibuprofen + Placebo

Acetaminophen + Maxigesic 325 + Ibuprofen + Placebo is a phase 3 stage product being developed by AFT Pharmaceuticals for Osteoarthritis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01420666. Target conditions include Osteoarthritis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01420666Phase 3Withdrawn

Competing Products

20 competing products in Osteoarthritis

See all competitors
ProductCompanyStageHype Score
Duloxetine + PlaceboEli LillyPhase 3
77
LY2828360 + PlaceboEli LillyPhase 2
52
Investigational Medical Product (IMP) administered in parent studyEli LillyPhase 3
77
Duloxetine + Sugar pillEli LillyApproved
85
UBX0101 or placeboUnity BiotechnologyPre-clinical
15
UBX0101Unity BiotechnologyPhase 1
25
UBX0101Unity BiotechnologyPhase 2
44
UBX0101Unity BiotechnologyPhase 1
25
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
52
Sodium hyaluronate + placebo injectionDaiichi SankyoPhase 3
77
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
52
Capsaicin Topical SolutionAstellas PharmaApproved
85
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
52
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
52
Duloxetine + PlaceboShionogiPhase 3
77
DuloxetineShionogiPhase 3
77
ONO-4474 Part A1 + Placebo Part A1 + ONO-4474 Part A2 + Placebo Part A2 + ONO-4474 Part B + Placebo Part B + ONO-4474 Part C + Placebo Part C + ONO-4474 Part D + Placebo Part DOno PharmaceuticalPhase 1
33
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
52
Duloxetine + PlaceboEli LillyPhase 3
77
LY3556050 + PlaceboEli LillyPhase 2
52

Other Products from AFT Pharmaceuticals

Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion)Phase 3
69
Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IVPhase 3
69
Maxigesic 325 + Acetaminophen + Ibuprofen + PlaceboPhase 3
69
Maxigesic® IVPhase 3
69
Combogesic® tablets + Acetaminophen 500mg + PlaceboPhase 3
69